Arkolith/Insider Trading/PBYI/Form 4

Auerbach Alan H

President and CEO, Director, 10% OwnerPUMA BIOTECHNOLOGY, INC. (PBYI) · full profile →Form 4 · filed Jan 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$205K
Net Open-Market Flow
-$205K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Sell(S)18K$5.88$106K7.1M
Jan 6, 2026Sell(S)17K$5.84$99K7.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-26-000924) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML